chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient noticed burning, tenderness at injection site after injection (injection at 9:45am).  Patient noticed a large welp and redness below injection around 5pm.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Feb2021 at 14:00 as dose 1, single (Batch/Lot number: unknown), in left arm, on 26Feb2021 at 13:00 as dose 2, single (Batch/Lot number: unknown), in right arm and on 01Nov2021 at 13:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 45 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 29May2022 at 17:00 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing); "type 2 diabetes" (unspecified if ongoing); "hypertension" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Doxycycline, reaction(s): "Known allergies: Doxycycline". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Patient received Anti-viral treatment for COVID-19 with Paxlovid from 24Aug2022 to 29Aug2022. Rebound COVID-19 after completing full 5 day Paxlovid treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
patient reported to pharmacy temperature of 101.2 degrees F at highest. stomach upset, severe headache and body aches.
Patient complained of getting fever, chills and felling sick. She reports that this lasted about a week. She did not seek treatment and reports feeling better now.
Information has been received from a registered nurse referring to a patient of unknown age and unknown gender. Medical history and drug allergy were not reported. On 14-MAY-2015 the patient was vaccinated with one dose of improperly stored (Merck) VARIVAX (dose, strength, route, lot# and expire date were not reported). Concomitant drug were not reported. No adverse effects were reported. It was unspecified if the patient sought any medical attention. Additional information has been requested.
c/o "I can't breathe, feels like my throat is closing" VS taken. Pt crying, breathing rapidly possibly hyperventilating. Epi IM given, VS taken. Hospital emergency activated. Rapid team arrived assessing pt. Rapid team escorted pt via gurney for further observation.
There has been a lot of info going around about being able to put/stick a coin to the site where you got your vaccine. My mom sent me a text with a picture where she had the coin sticking to where she got her vaccine done at. She sent a message to everyone in the family. Everyone has had the same experience. A dime or magnet will stick to your arm where the vax was given, we went to different locations and different vax timeframes. My mom got the moderna vax and the rest of us got the Pfizer vax.  My mom, stepdad, me, my partner, my brother all have the same experience with coins/magnets sticking to our arms. We all did great after both sets of vax with very little side effects.
(approximate times) 12:30pm - first vaccines ever administered (Hep B, DTaP, Hib, PCV, IPV). folloed by .6 ml of tylenol given by nurse. The combined Vaccine was given in his left leg and the two other single shots given in his right leg (                      ).Approx. 5 pm his right thigh (almost intirety)was inflamed, fever, and very very tender to touch.  He was in obvious agony. Approx. 6 pm the redness, fever and swelling ceased along with screaming.
patient developed an itchy rash after receiving GARDASIL 9/ rash that started 3 days ago (2/6). She got her 1st HPV vaccine here on 1/31. Her rash was waist up, itchy. We are pretty sure it is not related to the vaccine; This spontaneous report has been received from a nurse, concerning a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided.  On31-JAN-2023, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular Injection (dose, vaccination scheme, anatomical location, route of administration, frequency, lot number and expiration date were not provided for any of the suspects) for prophylaxis.  On 06-FEB-2023 (reported as three days ago), the patient experienced a rash. Her rash was waist up, itchy (rash pruritic). The outcome of the event rash pruritic was not provided.  The causality assessment between the event rash pruritic with the suspect hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was not related.
No adverse event; A expired vaccine was administer to a patient. Vaccine Expired on 04/01/2023 and it was administer 04/03/2023.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A expired vaccine was administer to a patient. Vaccine Expired on 04/01/2023 and it was administer 04/03/2023.) and NO ADVERSE EVENT (No adverse event) in a 28-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 044C22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: COVID-19 VACCINE on 28-Feb-2023. Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE.    On 03-Apr-2023, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-Apr-2023,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (A expired vaccine was administer to a patient. Vaccine Expired on 04/01/2023 and it was administer 04/03/2023.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A expired vaccine was administer to a patient. Vaccine Expired on 04/01/2023 and it was administer 04/03/2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (A expired vaccine was administer to a patient. Vaccine Expired on 04/01/2023 and it was administer 04/03/2023.).    No concomitant medications was provided. No treatment medications was provided. Vial size was  5.5mL  Date the vial was initially stored in the refrigerator was unknown. Reporter said the box just has expiration date but no date that it was moved from freezer to fridge. They only have the date they received them which was 28Nov2022. Normally the procedure was they write the date it was removed from the freezer to the fridge.
Red hot and swollen to injection site R thigh. Apply warm compres, TYLENOL or IBU PRN.
About 30 min after the vaccination I felt dizzy. It felt almost like I had gotten up too quickly and felt dizzy, that kind of dizziness. Lots of soreness on the injection site the day of the vaccination and also going down the arm if I tried to lift my arm it was painful, everything else was fine until 4:30PM when I started feeling chills and feverish. Around 9PM the cold chills were so awful I started crying because it was so uncomfortable. I took some Tylenol and it knocked me out. I felt cold and hot during the night. About 7AM the next morning I had hives, on my chest, arms and legs (red itchy, swollen) the chills have gone away in the morning. I took an Allegra around 8AM and it did work after 30 min to an hour. Then I went to see my allergist around 11AM and  the itchiness and redness had gone down a lot but the itchiness was still there. The allergist told me to take some more Allegra that day and it ended up working.
Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Additional Details: Patient noticed redness and itching on chest approximately 20 minutes after injection but no other reported symptoms. Patient had already had a hive like rash on arm prior to injection. Patient was advised to stay in store for further observation. After an hour of observation patient denied any further new symptoms and departed. She was advised to stay near town and to call 911 if she developed any other symptoms. Patient called 911 approximately 2 hours after departure and was taken to ER.
The mobile clinic vaccine team went to provide COVID-19 vaccines. The vaccine team gathered their vaccines from the pharmacy fridge kept in the pharmacy under their control. At the clinic, the team started to draw and provide vaccines. One of the associates working at the clinic checked the QR code and realized the Janssen vaccine expired. By the time the vaccine was checked, it was already given.
On June 01, 1999 the pt was exposed to another pt who had experienced varicella after vaccination of varicella. On June 8, 1999 the patient experienced a rash with three papules on the torso.
Patient called stating that she was at a rountine Cardiologist appointment and had told her, her symptoms and issues taking place. The Cardiologist told her to call and report her symptoms and reaction to Health Dept. Patient stated that she received her High Dose Flu Vaccine one 09/25/2023 and after receiving waited in the lobby for 20 mins and then left. Patient stated that she felt fine when she left. Then about 2 hours after vaccination she stated she started to feel bad and had a little difficulty breathing but was not concerned enough to go to Emergency Room. Patient also stated that they had sprayed bug spray in house and thought that might have been what contibribute to the breathing issues. However today 09/27/2023 her arm is redden and swollen and warm to touch. Patient was informed that this can be a normal side effect and encouraged to use cool/ warm compressed to help with the reddness and swelling. Patitnet stated that she was not concerned about the reddness or swelling that they has happened in the past when she received her Pneumonia vaccine. But due to her Cardioloist telling her to report she thought she would call and inform health department. Patient was let known that a report would be filled with VAERS.
Pt received Prevnar on 12/22/2004. Mother reported thigh was swollen twice the size, has fever of 100 degrees for few days, Call center no
When injecting the vaccine, the patient pulled away and had the needle drag across her arm causing a superficial scratch. There was very minimal bleeding. The area was cleared with a cotton ball and a small bandaid was applied. The entire dose of vaccine was not able to be administered due to the patient's jerking away before it could all be pushed into the muscle.
This spontaneous report as received from a nurse refers to a unknown number of patients of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On an unknown date the patients were inadvertently vaccinated with improperly stored with GARDASIL 9 (strength, dose, frequency and route were not reported) (incorrect product storage). No concomitant medication were reported. No adverse effects were reported. There was no product quality complaint. This is one of the two reports received from the same reporter (Case # 1512USA004100). Additional information is not expected as the reporter did not wish further contact.
Pneumovax PPV 23 administered 0815 2/16/05 in L upper arm subcutaneously.  RN noted red area 5 cm by 7 cm around vaccination site on 2/17/05.  No generalized signs/symptoms of reaction such as hives, itching, difficulty breathing, swelling. Vital Signs are stable.
Pt originally tested positive for COVID -19 10/19/2020.  PT received both doses of the pfizer COVID-19 vaccine on 2/8 and 3/1. Pt was hospitalized on 3/31 for syncope with pacemaker implantation.  Appeared to be asymptomatic for COVID-19, but had a positive SARS-CoV-2 PCR test on 4/1.
Patient came to our facility for his 2nd dose of Pfizer and was given Johnson and Johnson inadvertently.
Information has been received from a RN in a public health dept. who received a request for a consultation from a local preschool concerning a 45 month old who was vaccinated at age 12 months with varicella virus vaccine live. Subsequently the pt became symptomatic and was diagnosed with a case of chickenpox. It was unknown if medical attention was sought. No product quality complaint was involved. No further information is available.
Presented to ED with shortness of breath and low oxygen level. Diagnosed with COVID-19 4 days prior to going to the ED.SpOt was 76% on room air and was given oxygen. Was given regeneraron the day before She was given steroids. Patient was elderly with delirum and confusion so recovering at home with family would be better. Patient was discharged
Hepatitis B vaccine in their first year of life /  80% were seronegative as teenagers; This case was reported by a physician via call center representative and described the occurrence of hepatitis b antibody negative in unspecified number of patients who received DTPa-HBV-IPV (Pediarix) for prophylaxis.  On an unknown date, the patient received Hepatitis B vaccine. On an unknown date, more than 2 years after receiving Hepatitis B vaccine, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter had 50 patients between 14 to 17 years of age who received Hepatitis B vaccine in their first year of life and 80 percent were seronegative as teenagers. It was unknown what hepatitis B vaccines were administered to the patients. The reporter consented to follow up. This case has been linked with case US2021090083, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021090083:same reporter
passed out; paralyzed on his left side ever since; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 02Feb2021 (Batch/Lot number: unknown) as dose number unknown ,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEMIPLEGIA (medically significant) with onset Feb2021, outcome "unknown", described as "paralyzed on his left side ever since"; LOSS OF CONSCIOUSNESS (medically significant) with onset 02Feb2021 00:15, outcome "unknown", described as "passed out".  Clinical Course: Reporter had who had a Pfizer Covid vaccine on 02Feb2021. He passed out 15 minutes after receiving shot. He has been paralyzed on his left side ever since. Reporter asked if there was any way to get physical or mental health and financial thru Pfizer.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Pt recv vax on 1/20/99; on same day pt exp irritable, swollen/red/warm left knee &calf; dx=soft tissue injury; tx=ice
States right leg, from knee to groin area, is swollen approx. 2 X larger than normal. No increased erythema or induration noted. Doesn't appear to cause problems with walking. Swelling noted on 12/7/00 PM.
pt. received 2 doses of vaccination but they failed and pt. ended up covid + requiring Regn-cov administration
fatigue; itchy small bumps on stomach and back; itchy small bumps (hives) on stomach and back; fever; chills; sore muscles; sore/stiff joints; sore/stiff joints; headache; nausea; fatigue; swollen lymph nodes in shot arm; inappropriate schedule of vaccine administration; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 18Apr2021 at 16:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation (Inappropriate schedule of vaccine administered). The patient had no medical history. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) from an unknown date and for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 04Apr2021 at 16:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. On 19Apr2021 at 06:00, the patient experienced fever, chills, sore muscles, sore joints, stiff joints, headache, nausea, fatigue and swollen lymph nodes in the arm. On 20Apr2021, the patient experienced fatigue, headache, hives, itchy small bumps on the stomach and back. The patient did not receive any treatment for the reported events. The adverse event did not result in a doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event fever, chills, sore muscles, sore joints, stiff joints, headache, nausea, fatigue, swollen lymph nodes in the arm, fatigue, headache, itchy small bumps on stomach and back and hives were recovered on an unknown date in 2021.  No follow-up attempts are needed; information about the lot number cannot be obtained.
She experienced macular degeneration; Her vision changed and decreased; She had an inflammatory reaction; From the first dose, she also reports chills, fever, and fatigue; From the first dose, she also reports chills, fever, and fatigue; From the first dose, she also reports chills, fever, and fatigue; This spontaneous case was reported by a nurse and describes the occurrence of MACULAR DEGENERATION (She experienced macular degeneration) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced MACULAR DEGENERATION (She experienced macular degeneration) (seriousness criterion medically significant), VISUAL IMPAIRMENT (Her vision changed and decreased), INFLAMMATION (She had an inflammatory reaction), CHILLS (From the first dose, she also reports chills, fever, and fatigue), FATIGUE (From the first dose, she also reports chills, fever, and fatigue) and PYREXIA (From the first dose, she also reports chills, fever, and fatigue). At the time of the report, MACULAR DEGENERATION (She experienced macular degeneration), VISUAL IMPAIRMENT (Her vision changed and decreased), INFLAMMATION (She had an inflammatory reaction), CHILLS (From the first dose, she also reports chills, fever, and fatigue), FATIGUE (From the first dose, she also reports chills, fever, and fatigue) and PYREXIA (From the first dose, she also reports chills, fever, and fatigue) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included ACE inhibitor.  Treatment medication were not provided.  A retired nurse practitioner had called to report that after her Moderna COVID-19 vaccine, she experienced an inflammatory reaction, macular degeneration, her vision changed and decreased. She had an inflammatory reaction from the first dose.  Company Comment: This is a Spontaneous case concerning a 79-year-old female patient, with no medical history reported, who experienced the unexpected and serious event of Macular degeneration. Seriousness assessed due to medically significant event. It occurred on an unknown date after the first dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.   This case was linked to MOD-2022-463239 (Patient Link).; Sender's Comments: This is a Spontaneous case concerning a 79-year-old female patient, with no medical history reported, who experienced the unexpected and serious event of Macular degeneration. Seriousness assessed due to medically significant event. It occurred on an unknown date after the first dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.
is late for the second dose / The first dose was administrated oin January 2020; This case was reported by a pharmacist and described the occurrence of incomplete course of vaccination in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in January 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, patient did not received 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
Reaction to the Moderna COVID-19 Vaccine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (Reaction to the Moderna COVID-19 Vaccine) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reaction to the Moderna COVID-19 Vaccine) (seriousness criterion hospitalization). The patient was hospitalized for 7 days due to VACCINATION COMPLICATION. At the time of the report, VACCINATION COMPLICATION (Reaction to the Moderna COVID-19 Vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was provided.  No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Day of injection, no adverse affects. That evening after I went to bed, I was woken up by extreme pain and soreness at the injection site. I had a terrible time sleeping. It radiated into my shoulder and lasted for four days. I didn't sleep well at all the entire time and I was affected by the pain during the day as well. I also had extreme fatigue the next day after the vaccination but that only lasted for that day.
Pain left arm and all over body, muscle aches, felt feverish but didn't take temp, headache, lost appetite.